Foseco India (FOSECOIND)

FairStock Score: 17/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 17.36% and ROE of 21.90% show strong return on capital.
• Debt/Equity N/A implies a clean, conservative balance sheet.
• Promoter holding of 63.54% aligns interests with minority shareholders.
• Sales growth of 36.98% demonstrates strong demand and topline momentum.
• Piotroski F-Score of 7/9 indicates solid financial health.

Concerns

• P/E of 46.21 and P/B of 10.20 are expensive, leaving little margin of safety.
• Profit growth of 7.25% lags sales growth of 36.98%; latest quarterly net margin is roughly 8%.
• Dividend yield of 0.47% is negligible for income-seeking investors.
• FairStock Score of 28/100 and the reported free cash flow figure warrant caution.

AI Analysis

Foseco India has the traits Graham liked: an established speciality chemicals business, high promoter ownership of 63.54%, and impressive returns—ROE of 21.90% and ROCE of 17.36%. Debt/equity is not applicable, so the balance sheet is clean. The Piotroski F-score of 7/9 reinforces that the financial position is not deteriorating. These strengths suggest a niche franchise with a real moat; otherwise, capital would not earn so much. But price is everything. At ₹4,686.50, market cap is ₹4,014 Cr, or 46.21 times earnings and 10.20 times book value of ₹459.65. Such a premium is justified only by sustained growth, but profit has grown only 7.25% even as sales grew 36.98%. A 37% top-line jump has not converted to profit—latest quarter sales of ₹187 Cr produced only ₹15 Cr net profit, about 8% margin. This is the opposite of operating leverage; it points to rising costs, competition, or pricing pressure. At this P/E, the earnings yield is roughly 2.2%, far below what a conservative investor should accept, and the dividend yield of 0.47% offers no compensation while waiting. The reported free cash flow figure appears unreliable; I would need the actual cash flow statement to check quality of earnings. The FairStock score of 28/100 is a warning. The stock has fallen from ₹6,846 to ₹4,686, but a falling knife is not automatically a bargain. A wonderful business at a rich price remains a poor investment. I would stay on the sidelines until margins revive and cash generation confirms earnings, or until the price falls enough to provide a margin of safety.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer